Literature DB >> 25492070

DSM-5 and substance use disorders: clinicolegal implications.

Michael A Norko1, W Lawrence Fitch2.   

Abstract

Presumed distinctions between substance dependence and substance abuse have been at the heart of the development and utilization of substance-based diversion from criminal prosecution to treatment for the past several decades, including its use in drug courts. These distinctions have been promulgated by organized psychiatry since the publication of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) in 1980. With the release of DSM-5 and the replacement of abuse and dependence categories with a single use disorder construct, the legal grounds for diversion in many states now stand at odds with organized psychiatry and its adoption of recent science. This article reviews the scientific basis for the DSM's new classification scheme, the dilemmas posed for states with statutes that rely on the abuse/dependence distinction, and potential remedies for legislatures wishing to keep pace with evolving research and clinical practice.
© 2014 American Academy of Psychiatry and the Law.

Entities:  

Mesh:

Year:  2014        PMID: 25492070

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  2 in total

Review 1.  Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.

Authors:  Claire Leconte; Raymond Mongeau; Florence Noble
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

Review 2.  Cancer Pain Management: Comprehensive Assessment and Nonopioid Analgesics, Part 1.

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2017-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.